Abstract:Objective To explore the influence of acupuncture on neurotransmitter levels and cognitive function in patients with depressive episode of bipolar Ⅱ disorder. Methods A total of 72 patients with depressive episode of bipolar Ⅱ disorder admitted to Tangshan Fifth Hospital, Hebei Province, from January 2017 to December 2021 were selected, and divided into observation group (36 cases) and control group (36 cases) according to the random number table method. The control group was treated with Lithium Carbonate Tablets and Paroxetine Hydrochloride Tablets, and the observation group was treated with acupuncture on the basis of control group. The treatment lasted for eight weeks. The levels of serum neurotransmitters dopamine (DA), norepinephrine (NE), and 5-hydroxytryptamine (5-HT) were compared between two groups before and after treatment. The cognitive function of two groups before and after treatment was evaluated by the Hopkins verbal learning test-revised (HVLT-R), Wisconsin card sorting test (WCST), and continuous performance test (CPT) scores. Results After treatment, the levels of DA, NE, and 5-HT in two groups were higher than those before treatment, and those of observation group were higher than those of control group, the differences were statistically significant (P<0.05). After treatment, the scores of HVLT-R, WCST, and CPT in two groups were higher than those before treatment, and the CPT scores in observation group were higher than those in control group, the differences were statistically significant (P<0.05). Conclusion Acupuncture has a definite effect on patients with depressive episode of bipolar Ⅱ disorder, and is helpful to improve the serum neurotransmitter levels and cognitive function, which is worthy of clinical application.
周鑫1 刘全良2 李晓娟3 张学颖4 李献周5. 针刺对双相Ⅱ型障碍抑郁发作患者神经递质水平和认知功能的影响[J]. 中国医药导报, 2023, 20(17): 136-139.
ZHOU Xin1 LIU Quanliang2 LI Xiaojuan3 ZHANG Xueying4 LI Xianzhou5. Influence of acupuncture on neurotransmitter level and cognitive function in patients with depressive episode of bipolar Ⅱ disorder. 中国医药导报, 2023, 20(17): 136-139.
[1] 美国精神医学学会. 精神障碍诊断与统计手册(第五版)(DSM-5)[M].北京:北京大学出版社,2016.
[2] Bonnín CDM,Reinares M,Martínez-Arán A,et al. Improving Functioning,Quality of Life,and Well-being in Patients With Bipolar Disorder [J]. Int J Neuropsychopharmacol,2019, 22(8):467-477.
[3] 黄娟,付冰冰,杨帆.双相情感障碍抑郁发作急性期治疗后残留症状及其影响因素[J].神经疾病与精神卫生,2019,19(3):277-281.
[4] 袁铭,李素敏,王雪芹,等.双相抑郁的特点、危害及药物治疗研究进展[J].中国全科医学,2016,19(10):1229-1233.
[5] Shi J,Tian J,Wei M,et al. The utility of the Hopkins Verbal Learning Test(Chinese version) for screening dementia and mild cognitive impairment in a Chinese population [J]. BMC Neurol,2012,12:136.
[6] Kopp B,Lange F,Steinke A. The Reliability of the Wisconsin Card Sorting Test in Clinical Practice [J]. Assessment,2021,28(1):248-263.
[7] 田国强,甘建光.连续操作测验检测持续性注意功能[J].中国临床神经科学,2009,17(6):653-656.
[8] 于欣,方怡儒.中国双相障碍防治指南[M].北京:中华医学电子音像出版社,2014.
[9] 郑莉明,朱艳芳,敖海清,等.双相障碍的阴阳转化病机内涵及其指导意义[J].辽宁中医杂志,2017,44(3):506- 508.
[10] Ashok AH,Marques TR,Jauhar S,et al. The dopamine hypothesis of bipolar affective disorder:the state of the art and implications for treatment [J]. Mol Psychiatry,2017,22(5):666-679.
[11] 刘光伟,赵俊霞,赵栋,等.双相障碍患者血清中色氨酸羟化酶、5-羟色胺水平与临床特征的关系[J].国际检验医学杂志,2021,42(5):559-562,567.
[12] Pech J,Akh?覬j M,Forman J,et al. The impact of a new affective episode on psychosocial functioning,quality of life and perceived stress in newly diagnosed patients with bipolar disorder:A prospective one-year case-control study [J]. J Affect Disord,2020,277:486-494.
[13] 陈香,陈仁德,罗明.双相情感障碍不同临床分期患者脑磁共振波谱特征及其与认知功能损害的关系[J].神经疾病与精神卫生,2019,19(6):556-561.
[14] 于海婷,薄奇静,迟勇,等.缓解期抑郁障碍、双相情感障碍认知功能比较[J].中国医刊,2021,56(4):419-422.
[15] 余姝,王强,邓伟,等.双相障碍抑郁发作与重性抑郁障碍患者认知功能损害比较[J].临床精神医学杂志,2021, 31(2):130-133.
[16] Fountoulakis KN,Tohen M,Zarate CA Jr. Lithium treatment of Bipolar disorder in adults:A systematic review of randomized trials and meta-analyses [J]. Eur Neuropsychopharmacol,2022,54:100-115.
[17] 《上海医药》编辑部.碳酸锂(lithium carbonate)[J].上海医药,2020,41(S2):51-53.
[18] Scaini G,Valvassori SS,Diaz AP,et al. Neurobiology of bipolar disorders:a review of genetic components,signaling pathways,biochemical changes,and neuroimaging findings [J]. Braz J Psychiatry,2020,42(5):536-551.
[19] 张文静.奥氮平+碳酸锂治疗双相情感障碍躁狂发作的效果和用药安全性评价[J].中国医药科学,2021,11(23):231-233.
[20] 黄常荣,刘旺林,马小棉,等.喹硫平联合碳酸锂对双相情感障碍患者炎症反应及躁狂症状的影响[J].中国当代医药,2021,28(13):89-91.
[21] 段宝京,方灵芝,李晓明,等.氟西汀与帕罗西汀的Mini卫生技术评估[J].医药导报,2021,40(10):1361-1367.
[22] 王丽,吴凡.浙江省11家医院2013-2017年抗抑郁药使用分析[J].中国药房,2019,30(5):704-707.
[23] 邵青,张晓红,权伟,等.抗精神病药物引起的不良反应回顾性分析[J].中国医药导报,2021,18(14):156-159.
[24] 罗丁,牛淑芳,余芳倩,等.从“整合针灸”诊治抑郁障碍及其共病[J].广州中医药大学学报,2022,39(5):1168- 1173.
[25] 李毓莹,陈晓伟,阎路达,等.“疏肝调神”为指导的整合针灸模式治疗双相情感障碍经验[J].环球中医药,2022, 15(7):1227-1231.
[26] 李祎豪,吕建琴,李宁.针灸治疗精神障碍的临床研究概况[J].中国民间疗法,2022,30(8):117-119,125.
[27] 刘全良,周鑫,李晓娟,等.针灸治疗双相Ⅱ型障碍患者的临床效果[J].中国医药导报,2022,19(31):139-142.
[28] 浙江省中西医结合学会精神疾病专业委员会双相障碍学组.浙江省双相抑郁中西医结合诊治专家共识[J].精神医学杂志,2022,35(3):255-259.